P867: TUMOR PROFILING OF IDECABTAGENE VICLEUCEL (IDE‐CEL; BB2121) PATIENTS IN KARMMA SHOWED COMPARABLE RESPONSES IN EXISTING MOLECULAR HIGH‐RISK SUBSETS AND PRELIMINARY GENE SIGNATURE OF DURABLE RESPONSE

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 760 - 761
Main Authors Martin, N., Xu, A., Stong, N., Rytlewski, J., Finney, O., Campbell, T., Pierceall, W., Flynt, E., Thompson, E., Kaiser, S.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Online AccessGet full text

Cover

More Information
Bibliography:Authors contributed equally to this abstract.
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000846348.62497.10